Fact-checked by Grok 2 weeks ago

Protopine

Protopine is a benzylisoquinoline alkaloid with the molecular formula C₂₀H₁₉NO₅ and CAS number 130-86-9, naturally occurring in various plants of the Papaveraceae and Fumariaceae families, including Corydalis yanhusuo, Papaver somniferum (opium poppy), Fumaria officinalis, and Glaucium species. Derived biosynthetically from (S)-reticuline, it features a characteristic methyl substituent on the nitrogen atom and oxygen-containing groups on the aromatic rings, contributing to its pharmacological profile as a multifunctional bioactive compound. This alkaloid is renowned for its diverse therapeutic potential, acting as a histamine H₁ receptor antagonist, opioid-like analgesic, and inhibitor of platelet aggregation. Key pharmacological activities include antiarrhythmic effects by blocking multiple ion channels (such as I_Ca-L, I_Kr, and I_Na), which reduce ventricular fibrillation incidence in animal models; antihypertensive and cardioprotective properties; and anti-inflammatory, neuroprotective, and anticancer actions through mechanisms like apoptosis induction in tumor cells (e.g., IC₅₀ values of 6.68 µM for HL-60 leukemia cells and 20.47 µM for A-549 lung cancer cells). As of 2025, ongoing research explores its potential in breast cancer therapy, cardioprotection under hypoxic conditions, and antimicrobial activity against pathogens like Escherichia coli. Additionally, protopine demonstrates spasmolytic, smooth muscle stimulant, antibacterial, antifungal, and antimalarial effects, with low tissue residue levels (<6.5 ng/g) observed in pharmacokinetic studies following oral administration in rats. Protopine's metabolism involves phase I (demethylation, ring cleavage) and phase II () pathways, yielding multiple metabolites detectable in , urine, feces, and cecal contents, while its reveal wide tissue distribution but minimal accumulation. Although generally considered safe at therapeutic doses, it may exhibit in high concentrations and potential , as associated with certain alkaloid-rich plants, underscoring the need for further toxicological research. Traditionally used in medicine from tubers for pain relief and cardiovascular support, protopine continues to be investigated for its role in mitigating and as a component in herbal preparations for inflammatory and thrombotic conditions.

Chemical Characteristics

Molecular Structure

Protopine is a naturally occurring characterized by the molecular formula C₂₀H₁₉NO₅ and a of 353.37 g/mol. Its systematic IUPAC name is (13aS)-5,13a-dihydro-2,3,9,10-tetramethoxy-6H-dibenzo[f,g]isoquino[1,9a,3,4]oxadiazolo[3,2-a]azecin-7-one, though commonly referred to by its . This formula reflects its composition of 20 carbon atoms, 19 hydrogen atoms, one nitrogen atom, and five oxygen atoms, consistent with its classification as a protoberberine-derived . The core structure of protopine features a system composed of two rings (designated as rings A and C) fused and connected via a central ten-membered heterocyclic ring (ring B) that includes a atom. This arrangement incorporates groups on the rings and a functionality in the central ring, contributing to its rigidity and characteristic profile. The in the central ring is N-methylated, and the includes linkages from the groups. Protopine represents a ring-opened derivative of protoberberine alkaloids, where the B and C rings of the parent protoberberine skeleton undergo oxidative cleavage, resulting in the expanded central ring and altered connectivity. This structural modification distinguishes protopine within the family while maintaining biosynthetic ties to protoberberines.

Physical and Chemical Properties

Protopine is a white to light yellow crystalline solid at room temperature. Its melting point is 208 °C. The calculated density of protopine is 1.399 g/cm³. Protopine exhibits low solubility in water, rendering it practically insoluble under standard conditions. It demonstrates good solubility in organic solvents, including chloroform at a 1:15 ratio, ethanol, and acetone. The compound remains stable under ordinary storage conditions but is sensitive to light, which can lead to degradation. Spectroscopic techniques are essential for the identification and characterization of protopine. In ultraviolet-visible (UV-Vis) spectroscopy, it shows a maximum absorption at 293 nm in methanol (log ε = 3.93). Infrared (IR) spectroscopy reveals a characteristic peak at 1675 cm⁻¹ (KBr), attributable to carbonyl-amide interactions. For nuclear magnetic resonance (NMR), key ¹H NMR signals in acetone-d₆ (500 MHz) include multiplets at 2.04–3.83 ppm (8H, aliphatic protons), singlets at 5.93 and 5.97 ppm (each 2H, methylenedioxy groups), aromatic singlets and doublets between 6.63 and 6.91 ppm (4H), and a singlet at 1.88 ppm (3H, N-methyl).

Occurrence and Biosynthesis

Natural Sources

Protopine is primarily found in plants belonging to the family (including the Fumarioideae subfamily), where it occurs as a . Key species include (opium poppy), , , and . Concentration levels of protopine vary by plant species and tissue, with higher amounts typically in underground parts. In Corydalis yanhusuo tubers, protopine is a significant component of the profile, though levels fluctuate based on cultivation and processing conditions. In Papaver somniferum, protopine is a minor compared to dominant ones like . These protopine-containing plants are distributed across temperate regions globally. is native to and parts of , including the , while originates from the Mediterranean but is widely cultivated in (e.g., , ) and for medicinal and ornamental purposes. is widespread in , northern , and introduced to , often growing in disturbed soils. Many of these species are cultivated specifically for medicinal extraction in and . Protopine is typically isolated from plant roots or tubers through solvent-based methods. Common approaches involve or Soxhlet extraction using organic solvents such as or , which effectively dissolve the due to its solubility properties. These techniques allow for the separation of protopine from other alkaloids in the plant matrix. Commercially, protopine is available as a component of extracts, particularly in formulations like Yan Hu Suo ( ), where it contributes to the overall profile of pain-relief preparations. These extracts are processed into granules, powders, or tinctures and distributed through suppliers for medicinal use.

Biosynthetic Pathway

Protopine is biosynthesized in plants of the Papaveraceae family from the benzylisoquinoline alkaloid precursor (S)-reticuline through a series of five enzymatic transformations that establish its characteristic tetracyclic structure with a protoberberine core. The pathway begins with the berberine bridge enzyme (BBE), an FAD-dependent oxidoreductase, which catalyzes the stereospecific oxidation of (S)-reticuline to form the methylene bridge, yielding (S)-scoulerine and initiating the protoberberine skeleton. Subsequent steps involve cytochrome P450 monooxygenases: cheilanthifoline synthase (CHS, CYP719A5) converts (S)-scoulerine to (S)-cheilanthifoline via 3'-hydroxylation, followed by stylopine synthase (STS, CYP719A) that introduces a methylenedioxy bridge to produce (S)-stylopine. The pathway proceeds with (S)-tetrahydroprotoberberine N-methyltransferase (TNMT), which methylates (S)-stylopine at the nitrogen to form the quaternary salt (S)-cis-N-methylstylopine (also known as allocryptopine), setting the stage for ring modification. The final transformation is mediated by (S)-cis-N-methylstylopine 14-hydroxylase (MSH, CYP719A25), a cytochrome P450 enzyme that hydroxylates the C-14 position, triggering spontaneous C-N bond cleavage and ring opening to yield protopine. Although protopine 6-hydroxylase (P6H, CYP82N) is involved in downstream conversion to dihydrosanguinarine in related benzophenanthridine pathways, it is not required for protopine formation itself. This sequence can be visualized as a linear progression: (S)-reticuline → (S)-scoulerine → (S)-cheilanthifoline → (S)-stylopine → allocryptopine → protopine, highlighting the role of oxidative cyclization and rearrangement in structural diversification. The genetic regulation of protopine biosynthesis relies on a coordinated network of enzymes and oxidoreductases, primarily expressed in the sieve elements and laticifers of species such as and species. Transcription factors like WRKY regulate these s, ensuring compartmentalized synthesis within specialized plant cells. The protopine pathway represents a key branch in the diversification of protoberberine alkaloids, involving duplications that enable structural variations.

Pharmacological Profile

Biological Activities

Protopine exhibits diverse receptor interactions that contribute to its physiological effects. It acts as an at histamine H1 receptors, selectively binding without activation to block endogenous histamine actions, thereby modulating allergic responses. Additionally, protopine blocks voltage-gated calcium channels, suppressing calcium influx in vascular and neuronal tissues, which underlies its vasorelaxant and antiarrhythmic properties. The anti-inflammatory effects of protopine primarily involve inhibition of the signaling pathway, leading to reduced production of pro-inflammatory s such as TNF-α and IL-6. In lipopolysaccharide-stimulated macrophages, protopine attenuates activation by preventing IκBα phosphorylation and p65 nuclear translocation, thereby decreasing inflammatory mediator release. This mechanism has been demonstrated in models of acute , where protopine dose-dependently suppresses expression and formation. In the cardiovascular system, protopine inhibits platelet aggregation by interfering with ADP- and collagen-induced pathways. It suppresses ADP-evoked shape change and aggregation in , likely through interference with purinergic receptors and downstream signaling, while also reducing collagen-triggered responses via modulation of receptors. These actions contribute to its antithrombotic potential without significantly affecting pathways. Protopine displays antimicrobial properties, particularly against Gram-positive bacteria like Staphylococcus aureus, where it exhibits significant inhibitory activity with a minimum inhibitory concentration of 125 µg/mL. Its antibacterial mechanism may involve disruption of bacterial cell membranes or interference with essential enzymes, as observed in extracts rich in protopine from Hypecoum erectum. Against fungi, protopine shows weak to moderate activity toward Candida species, including C. albicans, contributing to the antifungal effects of alkaloid mixtures from plants like Glaucium oxylobum. The analgesic mechanism of protopine involves modulation of opioid receptors, particularly through activation of μ- and κ-subtypes, as evidenced by antagonism of its effects by in pain models. Furthermore, it inhibits (COX) enzymes, especially COX-2, reducing synthesis in inflamed tissues and enhancing pain relief in inflammatory conditions. These dual actions—opioid agonism and COX inhibition—provide a multifaceted approach to analgesia without strong sedative side effects at therapeutic doses.

Therapeutic Applications and Research

Protopine, a key in plants like (Yan Hu Suo), has been utilized in for its and properties, particularly in formulations aimed at relieving various types of pain, such as , abdominal discomfort, and menstrual pain associated with . These traditional applications stem from the herb's role in promoting blood circulation and alleviating qi stagnation, with protopine contributing to the overall pain-relieving effects observed in clinical practice over centuries. Modern research has explored protopine's potential in several therapeutic areas, including anti-cancer effects through induction of in tumor cells, such as those from liver, breast, and colon cancers, often via pathways involving ROS accumulation and activation. Studies have also investigated its anti-neurodegenerative properties, demonstrating in models of cerebral ischemia and tau pathology relevant to , with derivatives like bromo-protopine enhancing tau degradation via HDAC6 inhibition. Additionally, protopine exhibits activity by inhibiting platelet aggregation induced by agents like , arachidonic acid, and PAF, primarily through suppression of synthesis. Animal studies further support its vasodilatory effects, relaxing vascular in rabbit aorta and mesenteric arteries by modulating calcium influx and cAMP/cGMP levels. Clinical evidence for protopine remains limited, with most data derived from studies on extracts containing it; a controlled in humans showed that such extracts reduced intensity during cold pressor testing, suggesting potential for mild to moderate relief, including possible applications in management based on preclinical nitroglycerin-induced models. In terms of , protopine is considered a candidate for adjunct therapy in alternatives due to its effects mediated partly through activation, with filed in the 2010s for protopine total alkaloids and derivatives aimed at enhancing for veterinary and potential human uses. However, significant research gaps persist, including the absence of large-scale randomized controlled trials (RCTs) to confirm and , as well as incomplete data on long-term effects as of 2025, necessitating further clinical investigation to translate preclinical promise into approved therapies.

Safety and Toxicology

Toxicity and Side Effects

Protopine exhibits moderate acute toxicity, with an oral LD50 of approximately 313 mg/kg in mice, classifying it as toxic based on standard criteria. At high doses, symptoms include muscular weakness, severe ataxia, tremors, lethargy, convulsions, coma, and cyanosis, leading to death within 10–30 minutes in lethal exposures; autopsy findings reveal hemorrhage in the lungs, suggesting respiratory depression, along with congestion and edema in the heart, liver, kidney, and brain. Another study reports an oral LD50 of 482 mg/kg in ICR mice, with observed sedation and slowed movement as primary acute effects. Common side effects associated with protopine exposure include neurotoxic manifestations such as and , as well as gastrointestinal disturbances. Protopine demonstrates depressant properties, which may contribute to respiratory at high doses. High-dose acute exposure to protopine can cause , evidenced by liver , vacuolar degeneration, nuclear , and hyperemia in histopathological examinations of exposed . Low-dose studies (up to 48.2 mg/kg over 180 days) show no significant in rats. Regarding mutagenicity, genotoxicity assays including sperm abnormality, , and chromosome aberration tests are negative at doses up to 241 mg/kg. Protopine is contraindicated during due to demonstrated reproductive and embryonic developmental at doses exceeding 7.53 mg/kg, with a no-observed-effect level () at that threshold in models. As an isolated compound, protopine is not approved by the FDA for any therapeutic use. Extracts from plants like Macleaya cordata containing protopine are used in animal feed additives in some regions, but with dosage limits to avoid .

Pharmacokinetics and Metabolism

Protopine is rapidly absorbed following oral administration, with peak plasma concentrations achieved within a few hours in rat models. Studies in rats indicate an absolute oral bioavailability of approximately 25.8%, attributed to extensive first-pass metabolism in the liver rather than significant efflux inhibition by P-glycoprotein in the gut. The compound exhibits wide tissue distribution, reaching maximum concentrations in various organs including the liver (C_max ≈ 6.78 µg/mL at T_max ≈ 5.3 h) and lungs (C_max ≈ 11.42 µg/mL at T_max ≈ 5.1 h) after oral dosing in rats, suggesting higher affinity for these tissues. Protopine crosses the blood-brain barrier, enabling potential central nervous system effects. Metabolism of protopine occurs primarily in the liver through cytochrome P450 enzymes, including CYP2D1 and CYP2C11 in rats (homologous to human CYP2D6 and CYP3A4, respectively), leading to demethylation, ring cleavage, and subsequent glucuronidation or hydroxylation of metabolites. Identified metabolites include demethylated forms and those following the allocryptopine pathway, with over 10 phase I and II products detected in rat urine and feces; protopine itself undergoes rapid biotransformation, with negligible unchanged parent compound in circulation after 3 hours. Excretion is predominantly renal, with the majority of metabolites eliminated in within 24 hours post-administration in , while fecal elimination accounts for a smaller portion containing specific metabolites like demethylated derivatives; less than 1% of the dose is excreted unchanged. The elimination in is approximately 5 hours, reflecting efficient clearance. Pharmacokinetic parameters of protopine can vary with co-administration of certain compounds sharing structural features, such as , which may influence activity due to the common methylenedioxyphenyl moiety, potentially altering rates. Additionally, liver function impacts , as protopine exhibits hepatoprotective effects by inhibiting microsomal drug-metabolizing enzymes, though impaired hepatic could prolong exposure in disease states. Gender differences in biotransformation efficiency have been noted in studies, with potential implications for variability. Data on human and are limited, and further research is needed to assess clinical safety.

References

  1. [1]
    CAS 130-86-9 Protopine - Natural Products / BOC Sciences
    Protopine is an alkaloid isolated from the tubers of Corydalis yanhusuo W.T.Wang. It shows weak spasmolytic, smooth muscle stimulant activities.
  2. [2]
    Protopine - an overview | ScienceDirect Topics
    Protopine is defined as an isoquinoline alkaloid derived from Corydalis tubers, which exhibits antiarrhythmic, antihypertensive, and cardiovascular-protective ...
  3. [3]
    Biotransformation and tissue distribution of protopine and ... - Nature
    Jan 11, 2018 · The isoquinoline alkaloids protopine (PRO) and allocryptopine (ALL) are found primarily in the plant families Fumariaceae, Papaveraceae, ...
  4. [4]
    Protopine - an overview | ScienceDirect Topics
    Protopine is a histamine H1 antagonist, an analgesic agent with opioid effects, and a platelet aggregation inhibitor.
  5. [5]
    Identification and Quantification, Metabolism and Pharmacokinetics ...
    Dec 30, 2021 · Protopine possesses a wide range of pharmacological activities such as anti-inflammatory, anti-platelet aggregation, anti-cancer, analgesic, vasodilatory, ...
  6. [6]
    Protopine | C20H19NO5 | CID 4970 - PubChem - NIH
    Protopine is a benzylisoquinoline alkaloid occurring in opium poppies and other plants of the family papaveraceae. It has been found to inhibit histamine H1 ...6-Hydroxyprotopine
  7. [7]
    Recent Advances in Alkaloids from Papaveraceae in China - MDPI
    Protopine alkaloids constitute a class of natural isoquinoline compounds characterized by a basic three-ring structure, namely two benzene rings (A and C rings) ...
  8. [8]
    Protopine 130-86-9 | TCI AMERICA - TCI Chemicals
    Protopine; Product No: P2611; CAS RN: 130-86-9; Purity: >98.0%(GC) ... Melting Point, 203 °C. Specific Rotation, 0° (C=0.55,CHCl3). Maximum Absorption ...
  9. [9]
    Protopine and Allocryptopine Interactions with Plasma Proteins - MDPI
    The compound is also slightly soluble in water and has better solubility in organic solvents. Both compounds are stable under ordinary conditions but sensitive ...<|control11|><|separator|>
  10. [10]
    [PDF] An isoquinoline alkaloid, Protopine from Corydalis govaniana ...
    The physical constant and spectroscopic data ( IR, UV, NMR, MS) of the base were identical to those of protopine. This is the first report of the occurrence of ...
  11. [11]
    Protopine - an overview | ScienceDirect Topics
    Protopine is defined as an alkaloid found in Sanguinaria canadensis that contributes to its phytotherapeutic actions, which include effects such as expectorant ...
  12. [12]
    Metabolomic and evolutionary integration unveils medicinal ...
    Jul 1, 2025 · The dried tubers of cultivated Corydalis yanhusuo W.T. Wang, known ... Its protopine content is 2.91 mg/g, surpassed only by C.
  13. [13]
    Opium Alkaloids in Harvested and Thermally Processed Poppy Seeds
    Aug 26, 2020 · When the levels of the other alkaloids present in source #7 seeds, it was found that morphine (ND−4,754 ng/g) and codeine (2,361–14,607 ng/g) ...Missing: protopine Corydalis
  14. [14]
    Recent Advances in Alkaloids from Papaveraceae in China
    Aug 9, 2024 · Corydalis, the largest genus within the Papaveraceae family, consists of numerous species that have been historically used as medicinal plants ...Missing: somniferum officinalis
  15. [15]
    Screening Papaveraceae as Novel Antibiofilm Natural-Based Agents
    These are plants widespread in Europe, Asia, North America, and northern, eastern, and southern Africa. Most species are native to China and the Himalayas [4].
  16. [16]
    Solid-liquid extraction of protopine from Fumaria officinalis L.
    Aug 5, 2025 · For extracting thermally stable compounds, better extraction while using ethanol as solvent are achieved in shorter extraction time of 5 ...
  17. [17]
    Process for producing protopine total alkaloids extract
    208 ℃ of protopine fusing points.Be dissolved in chloroform, ethanol, ether, be slightly soluble in ethyl acetate, dithiocarbonic anhydride, benzene ...Missing: tubers | Show results with:tubers
  18. [18]
    Techniques for extraction and isolation of natural products
    Apr 17, 2018 · The conventional extraction methods, including maceration, percolation and reflux extraction, usually use organic solvents and require a large ...
  19. [19]
    Processing and Compatibility of Corydalis yanhusuo - NIH
    Dec 30, 2021 · We provide a summary of the phytochemistry, pharmacology, pharmacokinetics, quality control, and safety of C. yanhusuo under various processing or ...
  20. [20]
    Premium Corydalis Extract Powder Supplier | Nutri Avenue
    Derived from Corydalis yanhusuo (commonly known as Yan Hu Suo in Traditional Chinese Medicine), this herb is found in pain relief and mood support supplements.
  21. [21]
    Benzylisoquinoline alkaloid biosynthesis in opium poppy | Planta
    Mar 27, 2014 · Protopine alkaloids are formed via the 14-hydroxylation of quaternary protoberberine alkaloids, which leads to ring tautomerization through C–N ...
  22. [22]
    Modulation of benzylisoquinoline alkaloid biosynthesis by ...
    Oct 27, 2017 · In this study, we characterized the effects of ectopic expression of CjWRKY1, which is a transcriptional activator with many targets in BIA biosynthesis.
  23. [23]
    Analysis of the Coptis chinensis genome reveals the diversification ...
    Jun 2, 2021 · We identified diverse protoberberine-type alkaloids that occur predominantly in the rhizomes of C. chinensis, including extra high levels of ...
  24. [24]
    Ca(2+)-channel blockade in rat thoracic aorta by protopine isolated ...
    It is concluded that protopine relaxed the rat thoracic aorta mainly by suppressing the Ca2+ influx through both voltage- and receptor-operated calcium channels ...Missing: gated | Show results with:gated<|separator|>
  25. [25]
    Anti-Inflammatory Effect of Protopine through MAPK and NF-κB ...
    Jul 19, 2022 · Protopine is a substance used for hemostasis with an anti-inflammatory action and is one of the substances that are actively undergoing ...
  26. [26]
    Protopine attenuates inflammation stimulated by carrageenan and ...
    Collectively, these results suggest PTP has potential for attenuating CA- and LPS-induced inflammatory symptoms through modulation of MAPKs/NF-κB signaling ...
  27. [27]
    Antiplatelet effects of protopine isolated from Corydalis tubers
    Oct 15, 1989 · In rabbit platelet-rich plasma, protopine also inhibited the platelet aggregation caused by ADP, arachidonic acid, PAF and collagen. The ...
  28. [28]
    Anti-thrombotic and anti-inflammatory activities of protopine - PubMed
    Platelet aggregation induced by various platelet agonists (AA, ADP, collagen and PAF) was strongly inhibited by protopine in a concentration-related manner. The ...
  29. [29]
    Seven alkaloids and their antibacterial activity from Hypecoum ...
    Aug 6, 2025 · Protopine and allocryptopine, isolated from aerial parts of Hypecoum erectum L., showed significant antibacterial activity (MIC 125 µg/mL) ...
  30. [30]
    Antifungal activity of the methanolic extract and alkaloids of ...
    Four alkaloids, dicentrine, glaucine, protopine, and α-allocryptopine, were identified as the compounds responsible for the antifungal activity of this plant.
  31. [31]
    Opioid, calcium, and adrenergic receptor involvement in protopine ...
    Opioid, calcium, and adrenergic receptor involvement in protopine analgesia ... These results suggest that Pro displays its analgesic effect mainly through the ...
  32. [32]
    The Analgesic Properties of Corydalis yanhusuo - PubMed Central
    Dec 10, 2021 · Corydalis yanhusuo extracts (YHS) have been used for centuries as an analgesic agent in traditional Chinese medicine [13].
  33. [33]
    Corydalis - an overview | ScienceDirect Topics
    Corydalis is used in TCM, and called yanhusuo. It is an effective analgesic, sedative, and hypnotic, useful in the treatment of headache, insomnia, and ...
  34. [34]
    Protopine triggers apoptosis via the intrinsic pathway and regulation ...
    Protopine inhibited viabilities and triggered apoptosis via the intrinsic pathway in a caspase-dependent manner in liver carcinoma cells.Missing: modern research
  35. [35]
    Bromo-protopine, a novel protopine derivative, alleviates tau ...
    Our data strongly suggest that administration of the brain-permeable protopine derivative PRO-Br, could be a viable anti-tau therapeutic strategy for AD.
  36. [36]
    Identification and Quantification, Metabolism and Pharmacokinetics ...
    Dec 30, 2021 · Protopine (Figure 1B), C20H19NO5, is widely derived from a variety of plants, such as the Papaveraceae family (such as Corydalis yanhusuo W.T. ...
  37. [37]
    Effects of Corydalis yanhusuo and Angelicae dahuricae on Cold ...
    Mar 8, 2013 · Results from this study suggest that C. yanhusuo and A. dahuricae may have a potential clinical value for treating mild to moderate pain.Missing: relief migraine
  38. [38]
    Discovery of tetrahydropalmatine and protopine regulate the ...
    The results provide reliable evidence showing that the active substances tetrahydropalmatine and protopine from YHZTF lessens migraine symptoms in an in vivo ...
  39. [39]
    Potential Toxicity Evaluation of Protopine in Macleaya cordata (Willd ...
    The LD50 of protopine, the primary toxic component in M. cordata, was 313.10 mg/kg i.g., which was considered toxic, using the Miller and Tainter method. The ...
  40. [40]
    Acute, chronic, and genotoxic studies on the protopine total ... - NIH
    Sep 28, 2022 · The protopine alkaloids are widely distributed within the opium poppy family and have a wide range of pharmacological effects.
  41. [41]
    [PDF] Assessment report on Chelidonium majus L., herba
    Sep 13, 2011 · There is no restriction with regard to maximum doses specified. Bulgaria. Combination product containing 9 herbal preparations including ...
  42. [42]
  43. [43]
    Alkaloids in commercial preparations of California poppy
    In addition, excretion studies in rats have shown that protopine was mainly excreted in metabolized form (>99%) [29]. Therefore, metabolites of protopine ...
  44. [44]
    Effect of Wine and Vinegar Processing of Rhizoma Corydalis ... - MDPI
    The intra- and inter-day precision values (R.S.D.%) of THP, DHC and protopine in different tissue samples were all less than 5.83%. The relative extraction ...Missing: percentage | Show results with:percentage
  45. [45]
    Protopine Exerts Neuroprotective Effects on Neonatal Hypoxic ...
    Nov 5, 2024 · Protopine (Pro), an isoquinoline alkaloid, has anti-apoptotic and neuro-protective effects. However, the protective roles of Pro on neonatal ...
  46. [46]
    Identification of allocryptopine and protopine metabolites in rat liver ...
    Jun 8, 2016 · One demethylenated metabolite, two dioxolo-ring-opened metabolites and three tetrahydroprotoberberines metabolites were observed. However ...
  47. [47]
    Mechanism based CYP2D6 inhibition. (A) Piperine and protopine ...
    Mechanism based CYP2D6 inhibition. (A) Piperine and protopine both contain a methylenedioxyphenyl moiety which has been associated with mechanism-based ...